Could eating more berries and greens reduce your metabolic syndrome risk?
NCT ID NCT07354438
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a diet rich in antioxidants—like fruits, vegetables, whole grains, and legumes—can lower the risk of metabolic syndrome in adults aged 18 to 45. Metabolic syndrome includes high blood sugar, high blood pressure, unhealthy cholesterol, and excess belly fat. The 55 participants will follow this special diet, and researchers will measure changes in antioxidant intake and overall metabolic risk. The goal is to see if a simple dietary change can help prevent serious health problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Antioxidant-rich diet (fruits, vegetables, whole grains, legumes)
- What this could lead to
- If this works, it could show that a simple diet change helps reduce the risk of metabolic syndrome, a cluster of conditions that raise the chance of heart disease and diabetes.
- What could go wrong
- This is a small, early-stage study with only 55 participants, so results may not apply to everyone. Diet changes can be hard to stick with, and the effect on long-term health is still uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 55 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-45 years * Metabolic syndrome risk (abdominal obesity \& elevated BP as per NCEP ATP III criteria). * Low fruit \& veg intake (\<5 serv./day) as per WHO. * Willing to follow an intervention * Non-pregnant or lactating * Not diagnosed with malabsorption syndrome or chronic illness Exclusion Criteria: * Individuals \< 18 years or \> 45 years * Not at risk of metabolic syndrome. * Adequate intake of fruits \& veg (≥ 5 serv./day) as per WHO * Not willing * Pregnant or lactating * Diagnosed with malabsorption syndrome or chronic illness
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metabolic syndrome risk factors are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Veterinary & Animal Sciences, Lahore Pakistan
RECRUITINGLahore, Punjab Province, 54000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.